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INTRODUCTION
Approximately 20% of patients treated with pelvic
radiation develop bladder complications. Haematuria
occurs as a consequence of bladder injury in approxi-
mately 9% to 10% of patients after full-dose radiation.
Haematuria may develop months to years after treatment
and may be mild to catastropic.1–5 Haematuria from
radiation cystitis can be divided into three categories:
mild, moderate and severe. In mild cases, simple hydra-
tion and diuresis are usually adequate. In moderate and
severe haematuria, initial treatment usually involves
intravesicle instillation of chemical agents, including
silver nitrate, alum, prostaglandins and oestrogens.1,6–8
Formalin instillation is often effective for intractable haem-
orrhage unresponsive to other agents. Intravesicle forma-
lin instillation is effective in more than 80% of patients.
However, treatment is dose dependent and causes poten-
tially significant morbidity associated with formalin use.
A method of localized topical application of formalin
to treat profuse rectal bleeding due to radiation proctitis
was adapted for intravesicle use. The method does not
produce diffuse fixation of the bladder, resulting in a
decreased probability of detrusor fibrosis or upper tract
injury.1,5,9 We describe its use in eight cases of prolonged
bleeding secondary to radiation cystitis after failure of
other instillation techniques and compare it with standard
intravesicle formalin instillation.
OBJECTIVE: Intractable haemorrhage, secondary to radiation cystitis, is a serious complication of
radiotherapy for pelvic malignancies. Formalin instillation is often effective for intractable haemorrhage
unresponsive to other agents, but carries the risk of significant morbidity. The placement of formalin-
soaked pledgets is a modified technique for the treatment of this complication. We compare the
effectiveness and complications of both techniques.
METHODS: Eleven patients with intractable haemorrhage secondary to radiation cystitis were
treated by intravesicle 4% formalin instillation (Group I) and eight were treated by the endoscopic
placement of 10% formalin-soaked pledgets on the bleeding points for 15 minutes (Group II).
 RESULTS: Cessation of bleeding was 9/11 (82%) and 6/8 (75%) in Group I and Group II,
respectively. One patient in Group II required two treatments, due to recurrent haemorrhage. Four
major and several minor complications were found in Group I, and only three minor complications
were found in Group II.
CONCLUSION: Formalin instillation is effective in controlling severe bladder haemorrhage after
radiation of the pelvis, but the complications secondary to the fixative properties are severe. Topical
application of formalin-soaked pledgets is as effective in controlling the haemorrhage as conventional
intravesicle formalin instillation, with fewer complications. This technique should be the initial
treatment for this complication. (Asian J Surg 2002;25(3):232–5)
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PATIENTS
Nineteen women with intractable haematuria follow-
ing radiation therapy for cervical cancer were divided into
two groups. Eleven were treated with intravesicle 4%
formalin instillation, using the University of Chicago
protocol (Group I). Eight were treated with topical forma-
lin application (Group II). The average age in Groups I and
II was 50 ± 9.4 years (range, 44–64 years) and 58 ± 5.6
years (range, 54–71 years), respectively. The onset of
haematuria after radiation in Groups I and II was 6 ± 4
years (range, 1–13 years) and 5.6 ± 7 years (range, 0.5–21
years), respectively. Average follow-up time of Group I
was 25 months (range, 6–84 months) and for Group II was
15 months (range, 6–40 months). A profile of the patients
is shown in Table 1.
METHODS
All patients were evaluated cystoscopically for radiation
cystitis and a voiding cystogram was performed prior to
operation to rule out vesicoureteric reflux. All patients
had regional anaesthesia before the operation.
Group I
Intravesicle formalin was instilled following
the University of Chicago protocol by passively instilling
4% formalin solution up to about half of the volume of
the bladder capacity for 15 minutes, then irrigating the
bladder with normal saline via a 3-way Foley catheter for
12 to 24 hours.
Group II
 Patients in this group received topical application
of 10% formalin-soaked pledgets. A 24 F cystoscope
and an 8 F catheter were inserted into the bladder.
Carbon dioxide was used to inflate the bladder via a
laparoscopic insufflator. The bleeding points were
identified. Cotton pledgets, about 1 x 1 cm, were
soaked in 10% formalin and then placed cysto-
Table 2. Results of treatment
Group I Group II p value
Number of treatments 11 9
Success 9/11 (82%) 6/8 (75%) 0.05
Follow-up (months) 25 15
Operative time (minutes) 20 ± 6.7 (15–30) 110 ± 23.3 (80–160)
Complications
Major
- Anuria with bilateral hydronephrosis 2 -
- Vesicovaginal fistula 1 -
- Death (sepsis) 1 -
Minor
- Mild fever, tachycardia 3 -
- Frequency, dysuria 6 -
- Suprapubic pain 1 2
- Incontinence (transient) 1 1
Table 1. Profile of patients
Group I Group II
Number 11 8
Age (years) 50 ± 9.4 (range, 44–64) 58 ± 5.6 (range, 54–71)
Onset of haematuria after radiation (years) 6 ± 4 (range, 1–13) 5.6 ± 7 (range, 0.5–21)
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scopically, one at a time, at the bleeding points by
gasper for 15 minutes. The bladder was deflated after
each insertion. During the procedure, urine was drained
by gravity through an 8 F catheter placed alongside the
cystoscope. The average number of pledgets used was
5.5 (range, 4–6).
RESULTS
All areas of bleeding were stopped immediately
after the treatment and urine was clear within 24 hours
in 9/11 (82%) and 6/8 (75%) patients in Groups I and II,
respectively (p = 0.05). One patient in Group II required
a secondary operation due to recurrent bleeding (2
days after the first treatment).
Four major complications were found in Group I
(bilateral hydronephrosis with anuria [n = 2] and vesico-
vaginal fistula [n = 1] and death from sepsis [n = 1]),
but no major complications were found in Group II.
In addition, several minor complications were found
in Group I compared with Group II (Table 2). In all
successful cases of Group II, the postoperative voiding
symptoms were the same as that preoperatively.
Two patients who failed treatment with topical forma-
lin-soaked pledgets were successfully treated by
intravesicle formalin instillation without major
complications. The average duration of surgery in
Groups I and II was 20 ± 6.7 minutes (range, 15–30
minutes) and 110 ± 23.3 minutes (range, 80–160 minutes),
respectively.
DISCUSSION
Radiation accounts for 10% of all severe bladder
haemorrhage. Radiation to the pelvis, especially in full-
dose therapy required for pelvic malignancies, can cause
detrusor and mucosal injury, which may become manifest
at any time during, or after, initial treatment.1–5 The acute
effects of radiation on the bladder are noted first in the
mucosa (diffuse mucosal oedema). Vascular telangiectasia,
submucosal haemorrhage and interstitial fibrosis can
develop and, over the long term, may progress to smooth
muscle fibrosis. The most damaging effect in terms of
overall healing is an obliterative endarteritis, which results
in acute and chronic ischaemia of the vesicle wall.
Haematuria may be accompanied by symptoms of dysuria,
urgency and urinary frequency, secondary to reduced
bladder capacity and compliance.
Haematuria from radiation can be divided into several
categories according to the severity of bleeding. deVries
and Freiha divided haemorrhage into three categories:
mild, moderate and severe.2 Mild haematuria does not
produce an acute decrease in haematocrit and can be
controlled by simple measures, such as bladder irrigation
with water or saline, silver nitrate or alum. Moderate
haemorrhage produces a decrease in haematocrit over
several days and requires six units or less of transfused
packed red blood cells to maintain haemodynamic stability.
Treatment in this group may include open procedures or
hyperbaric oxygen 1,2,6,8,10–13 or formalin therapy.
Severe haematuria is defined as haemorrhage refrac-
tory to simple irrigation and requiring transfusion of more
than six units of packed red blood cells. These patients
usually require formalin instillation. Formalin (the aque-
ous solution of formaldehyde) appears to be the most
tested and reliable to arrest acute intractable haemorrhage.
Its advantage in treating haemorrhage is that it rapidly
fixes the bladder mucosa, preventing further necrosis,
sloughing and blood loss. It is reported to be up to 80%
effective in arresting bladder haemorrhage.2 The
disadvantage is that instillation is painful and requires
general or regional anaesthesia. The complication is
secondary to the fixative properties that include detrusor
fibrosis with loss of capacity, urinary incontinence due to
bladder neck or sphincteric injury and potential upper
tract obstruction from ureteral scarring in the pressure of
reflux and acute tubular necrosis.1–3,10,11
Complications after intravesicle formalin for
haemorrhage cystitis are divided into two groups: minor
and major complications. Minor complications are defined
as mild or transient medical problems or problems that do
not require surgical intervention. These include fever,
transient tachycardia, minor elevations of blood urea
nitrogen or creatinine, mild hydronephrosis, grades I to II
vesicoureteric reflux, frequency, urgency, incontinence,
suprapubic pain or a decrease in bladder capacity, not
requiring urinary diversion. Major complications are
defined as complications that damage the supravesicle
urinary tracts or those that require surgical intervention.
They include anuria, acute tubular necrosis, ureteral or
retroperitoneal fibrosis, ureterovesicular or ureteropelvic
junction obstruction, severe hydronephrosis, grades III to
IV vesicoureteric reflux and any vesicle fistula or a de-
crease in bladder capacity requiring urinary diversion.1
Lowe and Stamey reported localized topical applica-
tion of formalin to control haemorrhage due to radiation
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cystitis that was adapted from a similar method of treat-
ment for profuse rectal bleeding secondary to radiation
proctitis.5 This method does not produce diffuse fixation
of the bladder that may result in detrusor fibrosis or upper
tract injury. This modified technique of formalin-soaked
pledgets should be the initial treatment for controlling
haemorrhage after radiation and has few minor
complications. We can apply this technique in cases of
ureterovesicle reflux without upper urinary tract
involvement.5,9
CONCLUSION
Formalin instillation is effective in controlling severe
bladder haemorrhage after radiation to the pelvis, but
complications secondary to its fixative properties can be
severe. Topical application of formalin-soaked pledgets is
as effective a method for controlling haemorrhage as
conventional intravesicle instillation, but with fewer
complications. This technique should be the initial treat-
ment in controlling severe bladder haemorrhage.
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